Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4abde64a2a4ff6ea75befbbecf72f6d5 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2750-14143 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2830-008 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-0017 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
filingDate |
2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2022-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5376788aa68081b84aee7d867449e571 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed6d2b2ac5073087e5b54568c8a32622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d3c7d1d2583eab2605fc5c24cfddbce |
publicationDate |
2022-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2926677-T3 |
titleOfInvention |
Novel therapeutic tools and methods to treat blindness by targeting photoreceptors |
abstract |
The present invention relates to an isolated nucleic acid molecule comprising a nucleotide sequence encoding a light-gated depolarizing ion channel operably linked to a promoter leading to specific expression of said light-gated depolarizing channel in a photoreceptor. retinal, or nucleotide sequence complementary to said nucleotide sequence, for use in treating or ameliorating blindness. The present invention also relates to methods of using said nucleic acid molecules in the treatment of blindness. (Automatic translation with Google Translate, without legal value) |
priorityDate |
2015-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |